Zelda Therapeutics Broker/ Shareholders’ Brefing Lunch – Perth Shareholder Briefing Invitation: 4 July, Perth

A Green Fund exclusive interview with Dr. Richard Hopkins, Managing Director of Zelda Therapeutics. Zelda Therapeutics Ltd is an Australian-based bio-pharmaceutical company that aims to treat important diseases and disorders using cannabinoid-based medicines. Zelda Therapeutics – Pioneering Australian Medicinal Cannabis Research

Zelda Therapeutics Ltd (ASX:ZLD) is developing a range of cannabinoid-based formulations for the treatment of a variety of medical conditions, with a focus on cancer therapies. Zelda Therapeutics to outline cannabinoid-based strategy at Proactive CEO Sessions

The Board of Zelda Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF) is pleased toprovide this operational update with its Appendix 4C for the three-months to31 March 2019. March 2019 Quarterly Report

Start typing and press Enter to search

Shopping Cart